Back to search

Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice

Data up to Jan 2025

Published2010
Citations71
References22

Total Citations Per Year

Abstract

References (22)

Cancer Statistics, 2008

2008 • 10,165 citations

Targeting HIF-1 for cancer therapy

2003 • 6,321 citations

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

2006 • 5,595 citations

Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

2005 • 5,383 citations

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

2005 • 2,102 citations

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

2005 • 1,517 citations

General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.

1993 • 1,441 citations

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

2001 • 467 citations

Evaluation of HIF-1 inhibitors as anticancer agents

2007 • 358 citations

HIF-1 regulation: not so easy come, easy go

2008 • 315 citations

Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.

2004 • 272 citations

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

2007 • 258 citations

Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α

2004 • 204 citations

Prognostic significance of hypoxia-inducible factor-1 , TWIST1 and Snail expression in resectable non-small cell lung cancer

2009 • 200 citations

Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.

2003 • 158 citations

PX‐478, an inhibitor of hypoxia‐inducible factor‐1α, enhances radiosensitivity of prostate carcinoma cells

2008 • 103 citations

Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade

2007 • 88 citations

DEC1 (STRA13) protein expression relates to hypoxia‐ inducible factor 1‐alpha and carbonic anhydrase‐9 overexpression in non‐small cell lung cancer

2003 • 87 citations

Hypoxia Inducible Factor-1alpha and Vascular Endothelial Growth Factor in Biopsies of Small Cell Lung Carcinoma

2009 • 53 citations

Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas of the lung

2006 • 43 citations

Model of malignant pleural effusion of human lung adenocarcinoma in SCID mice.

1997 • 37 citations

HIF Gene Expression in Cancer Therapy

2007 • 25 citations

Cited By (0)

No citing papers found in database

Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic… (2010) – Journal of Thoracic Oncology | Metascience Observatory Explorer